CD4 and neoplasm: It has been reported that PD-1/PD-L1 interaction inhibits T lymphocyte proliferation, survival, and effector functions; promotes the differentiation of CD4+ T cells into Foxp3+ regulatory T (Treg) cells; and increases the resistance of tumor cells to cytotoxic T lymphocyte attacks [44].